These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 24492938)
21. DNA repair gene XRCC1 Arg194Trp polymorphism and susceptibility to hepatocellular carcinoma: A meta-analysis. Li W; Yang F; Gui Y; Bian J Oncol Lett; 2014 Oct; 8(4):1725-1730. PubMed ID: 25202399 [TBL] [Abstract][Full Text] [Related]
22. Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies. Jiang L; Fang X; Bao Y; Zhou JY; Shen XY; Ding MH; Chen Y; Hu GH; Lu YC PLoS One; 2013; 8(1):e55597. PubMed ID: 23383237 [TBL] [Abstract][Full Text] [Related]
23. The Arg194Trp polymorphism in the XRCC1 gene and cancer risk in Chinese Mainland population: a meta-analysis. Huang J; Zhang J; Zhao Y; Liao B; Liu J; Li L; Liao M; Wang L Mol Biol Rep; 2011 Oct; 38(7):4565-73. PubMed ID: 21499756 [TBL] [Abstract][Full Text] [Related]
24. Association between X-ray repair cross-complementation group 1 rs25487 polymorphism and pancreatic cancer risk. Jiang H; Wu D; Ma D; Lin G; Liang J; Jin J Tumour Biol; 2013 Dec; 34(6):3417-21. PubMed ID: 23807675 [TBL] [Abstract][Full Text] [Related]
25. Association between XRCC1 Arg399Gln polymorphism and hepatitis virus-related hepatocellular carcinoma risk in Asian population. Wu D; Jiang H; Gu Q; Zhang D; Li Z Tumour Biol; 2013 Oct; 34(5):3265-9. PubMed ID: 23780894 [TBL] [Abstract][Full Text] [Related]
26. The XRCC1 Arg194Trp and Arg280His polymorphisms in head and neck cancer susceptibility: a meta-analysis. Zhou X; Gu L; Zeng Y; Wei L; Ying M; Wang N; Su C; Wang Y; Liu C Tumour Biol; 2014 Nov; 35(11):10665-76. PubMed ID: 25062722 [TBL] [Abstract][Full Text] [Related]
27. Lack of association of XRCC1 rs1799782 genetic polymorphism with risk of pancreatic cancer: a meta-analysis. He G; Chen G; Chen W; Zhang W; Cao J; Ye Q Tumour Biol; 2014 May; 35(5):4545-50. PubMed ID: 24435745 [TBL] [Abstract][Full Text] [Related]
28. X-ray repair cross-complementing group 1(XRCC1) genetic polymorphisms and thyroid carcinoma risk: a meta-analysis. Qian K; Liu KJ; Xu F; Chen XY; Chen GN; Yi WJ; Zhou EX; Tang ZH Asian Pac J Cancer Prev; 2012; 13(12):6385-90. PubMed ID: 23464463 [TBL] [Abstract][Full Text] [Related]
29. Association of XRCC1 Arg399Gln and Arg194Trp polymorphisms with susceptibility to multiple autoimmune diseases: a meta-analysis. Peng M; Zhou X; Ding X; Wei L; Zhao Y; Zhu T; Shi X; Qin D Rheumatol Int; 2017 Mar; 37(3):435-444. PubMed ID: 27812739 [TBL] [Abstract][Full Text] [Related]
30. XRCC1 Arg399Gln and Arg194Trp polymorphisms in childhood acute lymphoblastic leukemia risk: a meta-analysis. Wang R; Hu X; Zhou Y; Feng Q; Su L; Long J; Wei B Leuk Lymphoma; 2013 Jan; 54(1):153-9. PubMed ID: 22712837 [TBL] [Abstract][Full Text] [Related]
31. XRCC1 gene polymorphisms and the risk of differentiated thyroid carcinoma (DTC): a meta-analysis of case-control studies. Bao Y; Jiang L; Zhou JY; Zou JJ; Zheng JY; Chen XF; Liu ZM; Shi YQ PLoS One; 2013; 8(5):e64851. PubMed ID: 23717668 [TBL] [Abstract][Full Text] [Related]
32. The polymorphism of XRCC1 and coronary artery disease risk: a meta-analysis. Guo SJ; Zhou YT; Liu WY; Zuo QN; Li XH Eur Rev Med Pharmacol Sci; 2017 Apr; 21(7):1559-1567. PubMed ID: 28429350 [TBL] [Abstract][Full Text] [Related]
33. Association between polymorphisms in XRCC1 gene and clinical outcomes of patients with lung cancer: a meta-analysis. Cui Z; Yin Z; Li X; Wu W; Guan P; Zhou B BMC Cancer; 2012 Feb; 12():71. PubMed ID: 22339849 [TBL] [Abstract][Full Text] [Related]
34. The Arg194Trp polymorphism in the X-ray repair cross-complementing group 1 gene as a potential risk factor of oral cancer: a meta-analysis. Zhou C; Zhou Y; Li J; Zhang Y; Jiang L; Zeng X; Feng X; Wang Z Tohoku J Exp Med; 2009 Sep; 219(1):43-51. PubMed ID: 19713684 [TBL] [Abstract][Full Text] [Related]
35. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and risk of childhood acute lymphoblastic leukemia: a meta-analysis. Wang L; Yin F; Xu X; Hu X; Zhao D PLoS One; 2012; 7(4):e34897. PubMed ID: 22529951 [TBL] [Abstract][Full Text] [Related]
36. The XRCC1 Arg194Trp polymorphism is not a risk factor for glioma: A meta-analysis involving 1,440 cases and 2,562 controls. Zhang L; Wang Y; Qiu Z; Luo J; Zhou Z; Shu W Exp Ther Med; 2012 Dec; 4(6):1057-1062. PubMed ID: 23226774 [TBL] [Abstract][Full Text] [Related]
37. XRCC1 polymorphisms are associated with cervical cancer risk and response to chemotherapy: a systematic review and meta-analysis. Shuai HL; Luo X; Yan RL; Li J; Chen DL Asian Pac J Cancer Prev; 2012; 13(12):6423-7. PubMed ID: 23464469 [TBL] [Abstract][Full Text] [Related]
38. X-ray repair cross-complementing group 1 (XRCC1) Arg399Gln polymorphism significantly associated with prostate cancer. Chen Y; Li T; Li J; Mo Z Int J Biol Markers; 2015 Feb; 30(1):e12-21. PubMed ID: 25262700 [TBL] [Abstract][Full Text] [Related]
39. XRCC1 Arg399Gln polymorphism contributes to increased risk of colorectal cancer in Chinese population. Tian Z; Li YL; Liu JG Mol Biol Rep; 2013 Jul; 40(7):4147-51. PubMed ID: 23712778 [TBL] [Abstract][Full Text] [Related]
40. Polymorphisms of XRCC1 and gastric cancer susceptibility: a meta-analysis. Chen B; Zhou Y; Yang P; Wu XT Mol Biol Rep; 2012 Feb; 39(2):1305-13. PubMed ID: 21604176 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]